{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:36:45Z","timestamp":1792190205465,"version":"4.4.0"},"reference-count":27,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Endourology"],"published-print":{"date-parts":[[2023,6]]},"abstract":"\n Purpose:<\/jats:title>\n The relationship between ureteral stent duration before percutaneous nephrolithotomy (PCNL) and infectious complications, admissions, imaging, and medical costs was evaluated.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n Patients who underwent PCNL within 6 months of ureteral stent placement were identified from commercial claims, categorized by time to treatment (0\u201330, 31\u201360, and >60 days), and followed 1-month post-PCNL. The effect of delayed treatment on inpatient admissions, infectious complications (pyelonephritis\/sepsis), and imaging utilization was evaluated with logistic regression. A generalized linear model evaluated the effect of delayed treatment on medical costs.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Among 564 patients with PCNL and meeting the inclusion criteria (mean age 50; 55% female; 45% from South), mean (standard deviation) time to surgery was 48.8 (41.8) days. Less than half (44.3%;\n n<\/jats:italic>\n \u2009=\u2009250) underwent PCNL within 30 days of ureteral stent placement, 27.0% (\n n<\/jats:italic>\n \u2009=\u2009152) between 31 and 60 days, and 28.7% (\n n<\/jats:italic>\n \u2009=\u2009162) >60 days. Time to PCNL was significantly associated with inpatient admissions (>60\n vs<\/jats:italic>\n \u226430 days odds ratio [OR] 1.97, 95% confidence interval [CI] 1.29\u20133.01,\n p<\/jats:italic>\n \u2009=\u20090.0016), infectious complications (>60\n vs<\/jats:italic>\n \u226430 days OR 2.43, 95% CI 1.55\u20133.81,\n p<\/jats:italic>\n \u2009=\u20090.0001), imaging utilization (31\u201360\n vs<\/jats:italic>\n \u226430 days OR 1.56, 95% CI 1.02\u20132.38,\n p<\/jats:italic>\n \u2009=\u20090.0383; >60\n vs<\/jats:italic>\n \u226430 days OR 2.01, 95% CI 1.31\u20133.06,\n p<\/jats:italic>\n \u2009=\u20090.0012), and medical costs (31\u201360\n vs<\/jats:italic>\n \u226430 days OR 1.27, 95% CI 1.08\u20131.49,\n p<\/jats:italic>\n \u2009=\u20090.0048; >60\n vs<\/jats:italic>\n \u226430 days OR 1.46, 95% CI 1.24\u20131.71,\n p<\/jats:italic>\n \u2009<\u20090.0001).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n Compared with PCNL within 30 days, patients undergoing PCNL >30 days after ureteral stent placement had increased likelihood of infectious complications, resource use, and medical costs. These results may inform health care resource utilization and PCNL prioritization.<\/jats:p>\n <\/jats:sec>","DOI":"10.1089\/end.2022.0489","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T11:26:24Z","timestamp":1681817184000},"page":"654-659","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Infectious Complications, Healthcare Resource Use, and Medical Costs Associated with Delays in Percutaneous Nephrolithotomy Among Patients with Stone Disease and Ureteral Stent Placement"],"prefix":"10.1177","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2679-2635","authenticated-orcid":false,"given":"Naeem","family":"Bhojani","sequence":"first","affiliation":[{"name":"Division of Urology, Centre Hospitalier de l'Universit\u00e9 de Montr\u00e9al, Montreal, QC, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutugandha","family":"Paranjpe","sequence":"additional","affiliation":[{"name":"Division of Urology, Boston Scientific, Marlborough, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Cutone","sequence":"additional","affiliation":[{"name":"Division of Urology, Boston Scientific, Marlborough, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Eisner","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"issue":"2","key":"e_1_3_5_2_2","first-page":"e86","article-title":"Kidney stones: A global picture of prevalence, incidence, and associated risk factors","volume":"12","author":"Romero V","year":"2010","unstructured":"Romero V, , Akpinar H, , Assimos DG. Kidney stones: A global picture of prevalence, incidence, and associated risk factors. Rev Urol, 2010; 12(2\u20133):e86\u2013e96.","journal-title":"Rev Urol"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3068365"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/2051415818813820"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2020.08.011"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00240-020-01210-w"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.03.052"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-017-2030-8"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1089\/end.2017.0225"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.02.036"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/end.2014.0681"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.08.043"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2016.11.028"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.05.090"},{"issue":"2","key":"e_1_3_5_15_2","first-page":"184","article-title":"Impact of ureteric stent on outcome of extracorporeal shockwave lithotripsy: A propensity score analysis","volume":"69","author":"Kaczmarek K","year":"2016","unstructured":"Kaczmarek K, , Go\u0142\u0105b A, , S\u0142ojewski M. Impact of ureteric stent on outcome of extracorporeal shockwave lithotripsy: A propensity score analysis. Cent Eur J Urol, 2016; 69(2):184\u2013189.","journal-title":"Cent Eur J Urol"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.05.091"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13796"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/end.1995.9.469"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.04.048"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOS-D-13-00009"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOS-D-15-00217"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e31825f64d0"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-014-3686-7"},{"issue":"1","key":"e_1_3_5_24_2","first-page":"S27","article-title":"Infections in patients with diabetes mellitus: A review of pathogenesis","volume":"16","author":"Casqueiro J","year":"2012","unstructured":"Casqueiro J, , Casqueiro J, , Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab, 2012; 16(Suppl. 1):S27\u2013S36.","journal-title":"Indian J Endocrinol Metab"},{"issue":"3","key":"e_1_3_5_25_2","first-page":"176","article-title":"[Is diabetes a risk factor of urinary tract infection in patients with ureteral obstruction? Results of a retrospective study]","volume":"75","author":"Moreau E","year":"2020","unstructured":"Moreau E, , Jorion JL, , Dardenne E, et al. [Is diabetes a risk factor of urinary tract infection in patients with ureteral obstruction? Results of a retrospective study]. Rev Med Liege, 2020; 75(3):176\u2013179.","journal-title":"Rev Med Liege"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11020310"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13250"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1089\/end.2015.0109"}],"container-title":["Journal of Endourology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/end.2022.0489","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/end.2022.0489","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/end.2022.0489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:15:07Z","timestamp":1777407307000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/end.2022.0489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1089\/end.2022.0489"],"URL":"https:\/\/doi.org\/10.1089\/end.2022.0489","relation":{},"ISSN":["0892-7790","1557-900X"],"issn-type":[{"value":"0892-7790","type":"print"},{"value":"1557-900X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}